308 related articles for article (PubMed ID: 16675720)
1. Atheroprotective potential of macrophage-derived phospholipid transfer protein in low-density lipoprotein receptor-deficient mice is overcome by apolipoprotein AI overexpression.
Valenta DT; Ogier N; Bradshaw G; Black AS; Bonnet DJ; Lagrost L; Curtiss LK; Desrumaux CM
Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1572-8. PubMed ID: 16675720
[TBL] [Abstract][Full Text] [Related]
2. Macrophage phospholipid transfer protein contributes significantly to total plasma phospholipid transfer activity and its deficiency leads to diminished atherosclerotic lesion development.
Vikstedt R; Ye D; Metso J; Hildebrand RB; Van Berkel TJ; Ehnholm C; Jauhiainen M; Van Eck M
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):578-86. PubMed ID: 17170377
[TBL] [Abstract][Full Text] [Related]
3. Macrophage phospholipid transfer protein deficiency and ApoE secretion: impact on mouse plasma cholesterol levels and atherosclerosis.
Liu R; Hojjati MR; Devlin CM; Hansen IH; Jiang XC
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):190-6. PubMed ID: 17038631
[TBL] [Abstract][Full Text] [Related]
4. Role of bone marrow-derived CC-chemokine receptor 5 in the development of atherosclerosis of low-density lipoprotein receptor knockout mice.
Potteaux S; Combadière C; Esposito B; Lecureuil C; Ait-Oufella H; Merval R; Ardouin P; Tedgui A; Mallat Z
Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1858-63. PubMed ID: 16763157
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol accumulation is increased in macrophages of phospholipid transfer protein-deficient mice: normalization by dietary alpha-tocopherol supplementation.
Ogier N; Klein A; Deckert V; Athias A; Bessède G; Le Guern N; Lagrost L; Desrumaux C
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2407-12. PubMed ID: 17717294
[TBL] [Abstract][Full Text] [Related]
6. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
Babaev VR; Ishiguro H; Ding L; Yancey PG; Dove DE; Kovacs WJ; Semenkovich CF; Fazio S; Linton MF
Circulation; 2007 Sep; 116(12):1404-12. PubMed ID: 17724261
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of human ApoAI transgene provides long-term atheroprotection in LDL receptor-deficient mice.
Valenta DT; Bulgrien JJ; Banka CL; Curtiss LK
Atherosclerosis; 2006 Dec; 189(2):255-63. PubMed ID: 16423356
[TBL] [Abstract][Full Text] [Related]
8. Acute elevation of plasma PLTP activity strongly increases pre-existing atherosclerosis.
Moerland M; Samyn H; van Gent T; van Haperen R; Dallinga-Thie G; Grosveld F; van Tol A; de Crom R
Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1277-82. PubMed ID: 18421000
[TBL] [Abstract][Full Text] [Related]
9. Macrophage PLTP is atheroprotective in LDLr-deficient mice with systemic PLTP deficiency.
Valenta DT; Bulgrien JJ; Bonnet DJ; Curtiss LK
J Lipid Res; 2008 Jan; 49(1):24-32. PubMed ID: 17928634
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-1 deficiency in bone marrow cells increases early atherosclerosis in apolipoprotein E- and low-density lipoprotein receptor-null mice.
Babaev VR; Ding L; Reese J; Morrow JD; Breyer MD; Dey SK; Fazio S; Linton MF
Circulation; 2006 Jan; 113(1):108-17. PubMed ID: 16380543
[TBL] [Abstract][Full Text] [Related]
11. Elevated expression of phospholipid transfer protein in bone marrow derived cells causes atherosclerosis.
van Haperen R; Samyn H; Moerland M; van Gent T; Peeters M; Grosveld F; van Tol A; de Crom R
PLoS One; 2008 May; 3(5):e2255. PubMed ID: 18509527
[TBL] [Abstract][Full Text] [Related]
12. Important role for bone marrow-derived cholesteryl ester transfer protein in lipoprotein cholesterol redistribution and atherosclerotic lesion development in LDL receptor knockout mice.
Van Eck M; Ye D; Hildebrand RB; Kar Kruijt J; de Haan W; Hoekstra M; Rensen PC; Ehnholm C; Jauhiainen M; Van Berkel TJ
Circ Res; 2007 Mar; 100(5):678-85. PubMed ID: 17293475
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow-derived multidrug resistance protein ABCB4 protects against atherosclerotic lesion development in LDL receptor knockout mice.
Pennings M; Hildebrand RB; Ye D; Kunne C; Van Berkel TJ; Groen AK; Van Eck M
Cardiovasc Res; 2007 Oct; 76(1):175-83. PubMed ID: 17560559
[TBL] [Abstract][Full Text] [Related]
14. Elevation of systemic PLTP, but not macrophage-PLTP, impairs macrophage reverse cholesterol transport in transgenic mice.
Samyn H; Moerland M; van Gent T; van Haperen R; Grosveld F; van Tol A; de Crom R
Atherosclerosis; 2009 Jun; 204(2):429-34. PubMed ID: 19100548
[TBL] [Abstract][Full Text] [Related]
15. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ
Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172
[TBL] [Abstract][Full Text] [Related]
16. Increased atherosclerotic lesions in apoE mice with plasma phospholipid transfer protein overexpression.
Yang XP; Yan D; Qiao C; Liu RJ; Chen JG; Li J; Schneider M; Lagrost L; Xiao X; Jiang XC
Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1601-7. PubMed ID: 12855484
[TBL] [Abstract][Full Text] [Related]
17. Conditional knockout of macrophage PPARgamma increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice.
Babaev VR; Yancey PG; Ryzhov SV; Kon V; Breyer MD; Magnuson MA; Fazio S; Linton MF
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1647-53. PubMed ID: 15947238
[TBL] [Abstract][Full Text] [Related]
18. P55 tumour necrosis factor receptor in bone marrow-derived cells promotes atherosclerosis development in low-density lipoprotein receptor knock-out mice.
Xanthoulea S; Gijbels MJ; van der Made I; Mujcic H; Thelen M; Vergouwe MN; Ambagts MH; Hofker MH; de Winther MP
Cardiovasc Res; 2008 Nov; 80(2):309-18. PubMed ID: 18628255
[TBL] [Abstract][Full Text] [Related]
19. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
[TBL] [Abstract][Full Text] [Related]
20. Egr-1 deficiency in bone marrow-derived cells reduces atherosclerotic lesion formation in a hyperlipidaemic mouse model.
Albrecht C; Preusch MR; Hofmann G; Morris-Rosenfeld S; Blessing E; Rosenfeld ME; Katus HA; Bea F
Cardiovasc Res; 2010 May; 86(2):321-9. PubMed ID: 20110335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]